Published in Hospital Business Week, February 25th, 2007
Study 1: Fresh data on cardiology are presented in the report "Lupeol and its ester inhibit alteration of myocardial permeability in cyclophosphamide administered rats." According to a study from Chennai, India, "Cyclophosphamide (CP), an alkylating agent widely used in cancer chemotherapy causes cardiac membrane damage. Lupeol, a pentacyclic triterpene, isolated from Crataeva nurvala stem bark and its ester, lupeol linoleate possess a wide range of medicinal properties."
"The effect of lupeol and its ester was evaluated in CP...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.